Notification Of Transactions Of Directors/PDMRs

RNS Number : 7504I

Zotefoams PLC

06 December 2022

 

Zotefoams plc

(the 'Company')

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

6 December 2022 - On 5 December 2022, the Company received notice from its Employee Benefit Trust of the exercise of nil cost options granted over ordinary shares of 5 pence each ('Shares') under the Company's Deferred Bonus Share Plan ('DBSP') at a sale price of £2.98 as follows:

Director	Award	Number of shares exercised and retained	Aggregate number of shares held
G C McGrath	DBSP 2020	23,021	94,261

Awards granted under the DBSP usually vest three years from grant, subject to satisfaction of service conditions. However, given the unprecedented circumstances brought about by COVID-19, and the decision of the Board not to recommend a final dividend for the year ended 31 December 2019, the proportion of the bonus that would normally have been paid in cash was deferred into shares (the 'Deferred Bonus proportion'). The Remuneration Committee has approved the exercise of the Deferred Bonus proportion taking place prior to 20 April 2023. The proportion of the bonus that would normally be deferred into shares (25%) will continue as normal and will be released after three years.

Under the terms of the award, the award was increased to reflect the dividends paid during the restricted period.

The Notification of Dealing Form can be found below.

This announcement is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE^® polyolefin and ZOTEK^® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT^® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce^® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA and Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE^®, ZOTEK^®, ReZorce^® and T-FIT^® are registered trademarks of Zotefoams plc.

ZOTEFOAMS PLC

DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name: Gary Christopher McGrath
2.	Reason for the notification
a)	Position/status: Group CFO
b)	Initial notification/Amendment: Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:  Zotefoams plc
b)	LEI: 213800B6P256B5XN8D32
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605
b)	Nature of the transaction: Exercise and retention under the Deferred Bonus Share Plan
c)	Price(s) and volume(s): Price(s) Volume(s) £2.98 23,021
d)	Aggregated information: Aggregate Price Aggregate Volume Aggregate Total £2.98 23,021 £68,602.58
e)	Date of the transaction: 5 December 2022
f)	Place of the transaction: XLON

 

END

 

 

DSHTFBLTMTIMMBT